Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Inventory (2016 - 2025)

United Therapeutics (UTHR) has disclosed Inventory for 17 consecutive years, with $183.1 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 15.96% to $183.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $183.1 million through Dec 2025, up 15.96% year-over-year, with the annual reading at $183.1 million for FY2025, 15.96% up from the prior year.
  • Inventory hit $183.1 million in Q4 2025 for United Therapeutics, up from $176.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $183.1 million in Q4 2025 to a low of $88.2 million in Q1 2022.
  • Historically, Inventory has averaged $121.1 million across 5 years, with a median of $103.8 million in 2023.
  • Biggest five-year swings in Inventory: fell 5.89% in 2022 and later soared 41.23% in 2024.
  • Year by year, Inventory stood at $93.8 million in 2021, then increased by 8.74% to $102.0 million in 2022, then grew by 9.61% to $111.8 million in 2023, then skyrocketed by 41.23% to $157.9 million in 2024, then grew by 15.96% to $183.1 million in 2025.
  • Business Quant data shows Inventory for UTHR at $183.1 million in Q4 2025, $176.5 million in Q3 2025, and $169.2 million in Q2 2025.